Literature DB >> 6411492

Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher disease.

A Maret, M Potier, R Salvayre, L Douste-Blazy.   

Abstract

The radiation inactivation method has been used to determine the molecular mass of membrane-bound acid beta-glucosidase (EC 3.2.1.21) in situ, in normal human spleen and in that of two patients with type I Gaucher disease: the molecular mass in Gaucher spleen is about double (125 000 +/- 8900) of that found in the normal spleen (67 000 +/- 7700) which is compatible with the existence of subunit coupling in the muted acid beta-glucosidase. From the results, we conclude that subunit interaction is altered in mutant acid beta-glucosidase and that this may be due to a direct effect of the mutation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411492     DOI: 10.1016/0014-5793(83)80943-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability.

Authors:  Raquel L Lieberman; J Alejandro D'aquino; Dagmar Ringe; Gregory A Petsko
Journal:  Biochemistry       Date:  2009-06-09       Impact factor: 3.162

2.  Altered molecular size of N-acetylglucosamine 1-phosphotransferase in I-cell disease and pseudo-Hurler polydystrophy.

Authors:  Y Ben-Yoseph; M Potier; D A Mitchell; B A Pack; S B Melançon; H L Nadler
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

3.  Interindividual heterogeneity of molecular weight of human brain neutral sphingomyelinase determined by radiation inactivation method.

Authors:  T Levade; R Salvayre; M Potier; L Douste-Blazy
Journal:  Neurochem Res       Date:  1986-08       Impact factor: 3.996

4.  Gaucher disease: heterologous expression of two alleles associated with neuronopathic phenotypes.

Authors:  M E Grace; A Berg; G S He; L Goldberg; M Horowitz; G A Grabowski
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.